Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$24.87 USD
-0.37 (-1.47%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $24.88 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Beam Therapeutics Inc. [BEAM]
Reports for Purchase
Showing records 81 - 100 ( 118 total )
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
BEAM-201 Development Candidate--Allo Cell Therapy for TALL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
SITC 2020 Abstract Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Financials; Data Through the End of the Year
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D